Clinical Trial Update: The Efficacy Study of Sodium Hyaluronate to Treat Symptomatic Hip Osteoarthritis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sodium hyaluronate for symptomatic hip osteoarthritis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip

Drugs mentioned

• Sodium Hyaluronate (sodium hyaluronate)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Symptomatic Hip Osteoarthritis | Phase 3 | Status: TERMINATED